Related Experiment Videos
The interrelationship between selective tau phosphorylation and microtubule association
H Xie1, J M Litersky, J A Hartigan
1Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 1720 Seventh Avenue S., SC1061, Birmingham, AL 35294-0017, USA.
Abstract:
The purpose of this study was to examine the modulation of tau phosphorylation mediated by protein kinase A, a kinase with low intrinsic activity, and by the constitutively active glycogen synthase kinase, as well as to examine the subsequent effects on tau-microtubule association in differentiated human SH-SY5Y neuroblastoma cells. Activation of protein kinase A with forskolin and rolipram significantly increased tau phosphorylation at Ser262/356 only in the presence of okadaic acid, indicating that phosphates at these sites are normally turned over rapidly. In contrast, glycogen synthase kinase appears to maintain tau phosphorylation at Thr181 and Ser396/404 since inhibition of glycogen synthase kinase with lithium reduced phosphorylation at these sites. Lithium treatment also significantly decreased tau and tyrosinated alpha-tubulin levels. Perturbation of microtubules with nocodazole or taxol induced tau dephosphorylation at Tau-1 sites, Thr181 and Ser396/404, indicating that both constitutive kinase activity and microtubule state modulate tau phosphorylation at these sites. Nocodazole- or taxol-induced tau dephosphorylation was blocked by the protein phosphatase 2A/1 inhibitor okadaic acid, but not by the protein phosphatase 2B inhibitor cyclosporin A. In addition, osmotic stress, such as treatment with 20 mM NaCl, selectively increased tau phosphorylation at the Tau-1 epitope. To investigate the effect of phosphorylation on tau association with microtubules and microtubule stability in situ, a Triton X-100 extraction assay was utilized to separate the detergent-soluble cytosolic components from the detergent-insoluble cytoskeletal components. In control cells or cells treated with lithium very little tau was detected in the cytosolic fraction. Activation of protein kinase A in the presence of okadaic acid elevated tau levels in the detergent-soluble fraction, which contained all the tau phosphorylated at Ser262/356, and also decreased microtubule stability, as indicated by decreased acetylated alpha-tubulin levels. In conclusion, the phosphorylation state of tau in differentiated SH-SY5Y cells is regulated by glycogen synthase kinase, microtubule dynamics and osmotic stress at overlapping sites which apparently have little influence on tau-microtubule association. In contrast, phosphorylation of tau at Ser262/356 within the microtubule-binding, which was mediated in part by protein kinase A, prevented the association of tau with microtubules in situ.
Insights
Glycogen synthase kinase and protein kinase A regulate tau phosphorylation at specific sites, influencing tau-microtubule interactions. Phosphorylation at Ser262/356 by protein kinase A disrupts tau binding to microtubules.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Tau protein phosphorylation is crucial for microtubule stability.
- Dysregulation of tau phosphorylation is implicated in neurodegenerative diseases.
- Specific kinases, such as glycogen synthase kinase (GSK) and protein kinase A (PKA), play roles in tau phosphorylation.
Purpose of the Study:
- To investigate how PKA and GSK modulate tau phosphorylation.
- To determine the effects of altered tau phosphorylation on tau-microtubule association.
- To examine these processes in differentiated human SH-SY5Y neuroblastoma cells.
Main Methods:
- Utilized differentiated human SH-SY5Y neuroblastoma cells.
- Employed forskolin and rolipram to activate PKA.
- Used okadaic acid (inhibitor of protein phosphatase 2A/1) and cyclosporin A (inhibitor of protein phosphatase 2B).
- Inhibited GSK with lithium.
- Perturbed microtubules using nocodazole or taxol.
- Assessed tau phosphorylation at specific sites (Ser262/356, Thr181, Ser396/404, Tau-1 epitope).
- Performed Triton X-100 extraction assays to analyze tau-microtubule association and microtubule stability (acetylated alpha-tubulin levels).
Main Results:
- PKA activation increased tau phosphorylation at Ser262/356 only with okadaic acid, suggesting rapid turnover.
- GSK inhibition by lithium reduced tau phosphorylation at Thr181 and Ser396/404.
- Lithium treatment decreased tau and tyrosinated alpha-tubulin levels.
- Microtubule disruption (nocodazole/taxol) induced tau dephosphorylation at Tau-1 sites (Thr181, Ser396/404), blocked by okadaic acid but not cyclosporin A.
- Osmotic stress (NaCl) increased tau phosphorylation at the Tau-1 epitope.
- PKA activation (with okadaic acid) increased soluble tau and decreased microtubule stability.
- Phosphorylation at Ser262/356 correlated with reduced tau-microtubule association.
Conclusions:
- Tau phosphorylation is regulated by GSK, microtubule dynamics, and osmotic stress at overlapping sites, with minimal impact on tau-microtubule association.
- Phosphorylation at Ser262/356, partly mediated by PKA, prevents tau association with microtubules in situ.
- These findings highlight distinct regulatory mechanisms for tau phosphorylation and its impact on microtubule binding.